Small molecule inhibitors in children with malignant gliomas.

Abstract

Pediatric high grade gliomas (HGG) remain difficult to cure despite recent advances in imaging, neurosurgery, and radiation. Current treatment modalities have demonstrated only modest survival benefit. Research utilizing molecular biologic techniques reveals that the phenotype of HGG is complex and results from dysregulation of numerous inter-related… (More)
DOI: 10.1002/pbc.21950

Topics

Cite this paper

@article{Herrington2009SmallMI, title={Small molecule inhibitors in children with malignant gliomas.}, author={Betty L. Herrington and Mark W Kieran}, journal={Pediatric blood & cancer}, year={2009}, volume={53 3}, pages={312-7} }